-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 10, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 10, 2012View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMay 9, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 9, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 4, 2012View HTMLDownload DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECMay 3, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 3, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 3, 2012View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionApr 30, 2012View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesApr 30, 2012View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerApr 27, 2012Download DOCDownload PDF
8-KReport of unscheduled material events or corporate eventApr 26, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 25, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 24, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 3, 2012View HTMLDownload DOCDownload PDF
CORRESPCorrespondence from the Filer to the SECApr 2, 2012View HTMLDownload DOCDownload PDFDownload XLS
ARSAn annual report to security holders.Mar 30, 2012View HTMLDownload DOCDownload PDF
DEFA14AAdditional proxy soliciting materials - definitiveMar 29, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 26, 2012View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerMar 23, 2012Download DOCDownload PDF
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Mar 23, 2012View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-125      126-150      151-154

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information